Travv
Category: AI in Healthcare
AI-native veterinary diagnostics platform starting with radiology workflows Travv was founded in 2025. The company is led by Derick Whitley. Based in Stillwater, Oklahoma. Team size: 2-10. Total funding raised: $1.6M. Latest round: Seed. Key investors include Digitalis Ventures; AniVC.
- Founded
- 2025
- Headquarters
- Stillwater, Oklahoma
- Team size
- 2-10
- Total funding
- $1.6M
Value proposition
Travv is building modern AI-native infrastructure for veterinary diagnostics, integrating RIS, PACS, and LIS capabilities into a single cloud-based platform that connects veterinarians with expert diagnosticians while using AI to streamline workflows.
Products and solutions
Travv Dx (AI-native cloud-based platform integrating RIS, PACS, and LIS); Global Teleradiology service; Cloud PACS; Data Annotation for Clinical AI; Pipeline of novel cloud-based diagnostics
Unique value
AI-first integrated diagnostic platform purpose-built for veterinary medicine, combining cloud-based RIS/PACS/LIS with AI-powered workflow automation and expert diagnostician network — replacing fragmented legacy systems with a unified modern experience.
Target customer
Veterinary hospitals and clinics; veterinary diagnosticians (radiologists, pathologists); veterinary telemedicine providers
Industries served
Veterinary Medicine; Animal Health; Veterinary Diagnostics; Veterinary Radiology
Technology advantage
AI-native architecture from day one (not retrofitting AI onto legacy systems); cloud-based platform unifies radiology, pathology, and lab data; team combines deep veterinary diagnostic expertise (board-certified pathologists/radiologists) with AI/ML engineering talent; data annotation capabilities for clinical AI development.
How they differentiate
Unlike SignalPET and Vetology which focus primarily on AI radiology interpretation, Travv is building a broader integrated diagnostic platform (RIS/PACS/LIS) with AI woven throughout, plus offering teleradiology services and data annotation. Travv's team brings deep veterinary pathology and radiology expertise alongside AI engineering talent.
Main competitors
SignalPET; Vetology AI; IDEXX (Imagyst)
Major milestones
Founded 2025; Launched radiology service and Cloud PACS in early 2026; First conference presence at VMX 2026; Closed $1.6M seed round led by Digitalis Ventures (May 2026)
Market positioning
Early-stage entrant in the veterinary AI diagnostics market, competing against established players (IDEXX, Zoetis, Antech) and AI-native startups (SignalPET, Vetology). Positioned as an integrated platform company rather than a point-solution AI tool.
Geographic focus
US (headquartered in Stillwater, Oklahoma); global ambitions with international advisor for Asia market
About Derick Whitley
Ex-Chief Medical Officer at Vidium Animal Health; VP of Strategy, Innovation & Diagnostics at Vidium Animal Health; Assistant Chief of Anatomic Pathology at Antech Diagnostics; Anatomic Pathologist at Antech Diagnostics. DVM from Oklahoma State University; DACVP (Diplomate of the American College of Veterinary Pathologists). Led digital pathology transformation at scale in veterinary diagnostics.
Official website: https://travv.com